根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001437749-22-001895 Act: 33 Size: 31 KB 网页链接
$Isoray(ISR)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001437749-22-001896 Act: 33 Size: 68 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-028900 Act: 34 Size: 300 KB 网页链接
$Isoray(ISR)$ 8-K Current report, item 5.07 Accession Number: 0001437749-21-028242 Act: 34 Size: 174 KB 网页链接
$Isoray(ISR)$ 内部交易: 2021-11-23,CEO,Woods Lori A ,期权,125000普通股, $0.45
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-027408 Size: 11 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-027304 Act: 34 Size: 210 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-21-026483 Act: 33 Size: 554 KB 网页链接
$Isoray(ISR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-026208 Act: 34 Size: 3 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-21-026147 Act: 34 Size: 278 KB 网页链接